PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 34363189-7 2021 Clarithromycin use was associated with decreases in circulating C-reactive protein, tumour necrosis factor-alpha and interleukin (IL)-6; by increase of production of interferon-gamma and decrease of production of interleukin-6 by mononuclear cells; and by suppression of SARS-CoV-2 viral load. Clarithromycin 0-14 C-reactive protein Homo sapiens 64-82 22687800-2 2012 Subsequently she received four weeks of oral levofloxacin and eight weeks of oral clarithromycin due to persistent elevation of C-reactive protein. Clarithromycin 82-96 C-reactive protein Homo sapiens 128-146 33552084-7 2020 In this model, the combination of E-CRP and clarithromycin drastically reduced bacteremia and increased survival of mice when compared to the protective effects of either E-CRP or clarithromycin alone. Clarithromycin 180-194 C-reactive protein Homo sapiens 36-39